Hims & Hers Health, Inc. (HIMS)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. (“Hims” or “the Company”) (NYSE: HIMS). Investors who purchased Hims securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Hims has violated federal securities laws.
Hims Investigation Details
On July 29, 2026, the Federal Trade Commission (“FTC”) filed a lawsuit against Hims, accusing it of sharing customers’ medical information with third-party advertisers. The FTC’s criminal complaint accuses Hims of “deceptive and unlawful privacy practices,” including sharing sensitive details about patient health with Meta Platforms, Snap and Facebook’s parent company. On this news, Hims’ stock price fell $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026. Then, on August 21, 2026, Bloomberg reported that Hims was put on notice by Visa Inc. for excessive customer complaints in its weight-loss subscription business, according to internal documents, adding to mounting scrutiny of its billing and cancellation policies. Reportedly, the Company was enrolled in Visa’s Acquirer Monitoring Program after a surge of customer credit card disputes in July, according to the documents seen by Bloomberg. Each dispute will carry an $8 surcharge, resulting in a nearly $75,000 bill that will hit in September, the documents reportedly said. Following this news, Hims’ stock price fell $2.70 per share, or 7.99%, to close at $31.08 per share on August 24, 2026.
What’s Next for Hims Investors?
If you are aware of any facts relating to this investigation or purchased Hims securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Hims Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC For Hims Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,” said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.